Literature DB >> 21514555

Severity of bacterial vaginosis and the risk of sexually transmitted infection.

Jenifer E Allsworth1, Jeffrey F Peipert.   

Abstract

OBJECTIVE: The purpose of this study was to determine whether the association between bacterial vaginosis (BV) and incident sexually transmitted infection (STI) varies with more extreme BV scores. STUDY
DESIGN: We analyzed the data from 535 women who were enrolled in a randomized trial to promote dual method contraceptive use. Incident STI was defined as any case of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, or pelvic inflammatory disease. BV was defined by Gram stain (Nugent score). STI risk was estimated with the use of proportional hazards regression.
RESULTS: Binary (0-6 vs 7-10) and 3-level (negative 0-3, intermediate 4-6, or BV 7-10) categorizations were not associated with time to STI; however, women with the highest Nugent scores (9-10) had a 2.1-fold increased risk of STI (95% confidence interval, 1.05-4.28), compared with women with normal flora.
CONCLUSION: Nugent score>8 is associated with incident STI. More accurate classification of BV will allow clinicians to identify those women who are at greatest risk of STI.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21514555      PMCID: PMC3156883          DOI: 10.1016/j.ajog.2011.02.060

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  31 in total

1.  Higher-risk behavioral practices associated with bacterial vaginosis compared with vaginal candidiasis.

Authors:  Catriona Susan Bradshaw; Anna N Morton; Suzanne M Garland; Margaret B Morris; Lorna M Moss; Christopher K Fairley
Journal:  Obstet Gynecol       Date:  2005-07       Impact factor: 7.661

2.  Design of a stage-matched intervention trial to increase dual method contraceptive use (Project PROTECT).

Authors:  Jeffrey Peipert; Colleen A Redding; Jeffrey Blume; Jenifer E Allsworth; Karen Iannuccillo; Faye Lozowski; Kenneth Mayer; Patricia J Morokoff; Joseph S Rossi
Journal:  Contemp Clin Trials       Date:  2007-02-07       Impact factor: 2.226

3.  Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation.

Authors:  R P Nugent; M A Krohn; S L Hillier
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

4.  Predictors of seropositivity to herpes simplex virus type 2 in women.

Authors:  B A Evans; P D Kell; R A Bond; K D MacRae; M J Slomka; D W G Brown
Journal:  Int J STD AIDS       Date:  2003-01       Impact factor: 1.359

5.  Among pregnant women with bacterial vaginosis, the hydrolytic enzymes sialidase and prolidase are positively associated with interleukin-1beta.

Authors:  Sabina Cauci; Jennifer Flatow Culhane; Manuela Di Santolo; Kelly McCollum
Journal:  Am J Obstet Gynecol       Date:  2007-08-22       Impact factor: 8.661

6.  Correlation of local interleukin-1beta levels with specific IgA response against Gardnerella vaginalis cytolysin in women with bacterial vaginosis.

Authors:  Sabina Cauci; Silvia Driussi; Secondo Guaschino; Miriam Isola; Franco Quadrifoglio
Journal:  Am J Reprod Immunol       Date:  2002-05       Impact factor: 3.886

7.  Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream.

Authors:  J A McGregor; J I French; W Jones; K Milligan; P J McKinney; E Patterson; R Parker
Journal:  Am J Obstet Gynecol       Date:  1994-04       Impact factor: 8.661

8.  Bacterial vaginosis in sexually experienced and non-sexually experienced young women entering the military.

Authors:  Sophia Yen; Mary-Ann Shafer; Jeanne Moncada; Christopher J Campbell; Scott D Flinn; Cherrie B Boyer
Journal:  Obstet Gynecol       Date:  2003-11       Impact factor: 7.661

9.  Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations.

Authors:  R Amsel; P A Totten; C A Spiegel; K C Chen; D Eschenbach; K K Holmes
Journal:  Am J Med       Date:  1983-01       Impact factor: 4.965

10.  Time course of the regression of asymptomatic bacterial vaginosis in pregnancy with and without treatment.

Authors:  Mark A Klebanoff; John C Hauth; Cora A MacPherson; J Christopher Carey; R Phillips Heine; Ronald J Wapner; Jay D Iams; Atef Moawad; Menachem Miodovnik; Baha M Sibai; J Peter vanDorsten; Mitchell P Dombrowski
Journal:  Am J Obstet Gynecol       Date:  2004-02       Impact factor: 8.661

View more
  37 in total

1.  Chlamydial plasmid-encoded virulence factor Pgp3 neutralizes the antichlamydial activity of human cathelicidin LL-37.

Authors:  Shuping Hou; Xiaohua Dong; Zhangsheng Yang; Zhongyu Li; Quanzhong Liu; Guangming Zhong
Journal:  Infect Immun       Date:  2015-09-28       Impact factor: 3.441

2.  Periodic Presumptive Treatment for Vaginal Infections May Reduce the Incidence of Sexually Transmitted Bacterial Infections.

Authors:  Jennifer E Balkus; Lisa E Manhart; Jeannette Lee; Omu Anzala; Joshua Kimani; Jane Schwebke; Juma Shafi; Charles Rivers; Emanuel Kabare; R Scott McClelland
Journal:  J Infect Dis       Date:  2016-02-04       Impact factor: 5.226

3.  Interactions among urogenital, intestinal, skin, and oral infections in pregnant and lactating Panamanian Ngäbe women: a neglected public health challenge.

Authors:  Doris González-Fernández; Kristine G Koski; Odalis Teresa Sinisterra; Emérita Del Carmen Pons; Enrique Murillo; Marilyn E Scott
Journal:  Am J Trop Med Hyg       Date:  2015-03-30       Impact factor: 2.345

4.  Lactobacillus iners-dominated vaginal microbiota is associated with increased susceptibility to Chlamydia trachomatis infection in Dutch women: a case-control study.

Authors:  Robin van Houdt; Bing Ma; Sylvia M Bruisten; Arjen G C L Speksnijder; Jacques Ravel; Henry J C de Vries
Journal:  Sex Transm Infect       Date:  2017-09-25       Impact factor: 3.519

Review 5.  Microbiota and pelvic inflammatory disease.

Authors:  Harsha Sharma; Reshef Tal; Natalie A Clark; James H Segars
Journal:  Semin Reprod Med       Date:  2014-01-03       Impact factor: 1.303

6.  Risk of bacterial vaginosis in users of the intrauterine device: a longitudinal study.

Authors:  Tessa Madden; Jaclyn M Grentzer; Gina M Secura; Jenifer E Allsworth; Jeffrey F Peipert
Journal:  Sex Transm Dis       Date:  2012-03       Impact factor: 2.830

7.  Association between obesity and bacterial vaginosis as assessed by Nugent score.

Authors:  Rita T Brookheart; Warren G Lewis; Jeffrey F Peipert; Amanda L Lewis; Jenifer E Allsworth
Journal:  Am J Obstet Gynecol       Date:  2019-01-29       Impact factor: 8.661

8.  Interleukin-36γ Is Elevated in Cervicovaginal Epithelial Cells in Women With Bacterial Vaginosis and In Vitro After Infection With Microbes Associated With Bacterial Vaginosis.

Authors:  Jameson K Gardner; Paweł Łaniewski; Anna Knight; Lisa B Haddad; Alison Swaims-Kohlmeier; Melissa M Herbst-Kralovetz
Journal:  J Infect Dis       Date:  2020-03-02       Impact factor: 5.226

9.  Socioeconomic-related risk and sexually transmitted infection among African-American adolescent females.

Authors:  Jessica M Sales; Erica L Smearman; Andrea Swartzendruber; Jennifer L Brown; Gene Brody; Ralph J DiClemente
Journal:  J Adolesc Health       Date:  2014-06-25       Impact factor: 5.012

Review 10.  Bacterial vaginosis-A brief synopsis of the literature.

Authors:  Makella S Coudray; Purnima Madhivanan
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2019-12-24       Impact factor: 2.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.